Glaxis Capital Management, LLC Tandem Diabetes Care Inc Transaction History

Glaxis Capital Management, LLC

  • $23.3 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$53.22 - $123.09 $266,100 - $615,450
-5,000 Closed
0 $0
Q1 2022

May 10, 2022
BUY
$101.89 - $150.09 $509,450 - $750,450
5,000 New
5,000 $581,000

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.31B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Glaxis Capital Management, LLC Portfolio

Follow Glaxis Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glaxis Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glaxis Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email